@article{ATM26810,
author = {Hirva Mamdani and Shadia I. Jalal},
title = {Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {The past decade has witnessed a paradigm shift in the treatment of cancer, moving from ‘one size fits all’ to a more precision medicine-based approach owing to the development of molecular diagnostic technologies capable of identifying an increasing number of actionable genomic alterations in the tumor tissue and circulating tumor DNA.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/26810}
}